Top 3 Swedish Growth Stocks With High Insider Ownership In September 2024

In This Article:

As European inflation nears the central bank's target, the pan-European STOXX Europe 600 Index has reached record highs, reflecting a positive sentiment in the market. Against this backdrop, identifying growth companies with high insider ownership can be a prudent strategy for investors seeking stability and confidence in their investments. In Sweden, several growth stocks stand out due to significant insider ownership, which often signals strong belief in the company's future prospects by those who know it best. Here are three such Swedish growth stocks to watch in September 2024.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name

Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)

16.9%

24.8%

Truecaller (OM:TRUE B)

29.5%

21.6%

Fortnox (OM:FNOX)

21.1%

22.6%

Magle Chemoswed Holding (OM:MAGLE)

14.9%

72.2%

Biovica International (OM:BIOVIC B)

18.8%

73.1%

BioArctic (OM:BIOA B)

34%

98.4%

Yubico (OM:YUBICO)

37.5%

42.5%

KebNi (OM:KEBNI B)

37.8%

86.1%

InCoax Networks (OM:INCOAX)

19%

115.5%

Calliditas Therapeutics (OM:CALTX)

12.7%

51.9%

Click here to see the full list of 92 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

BioArctic

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden and has a market cap of SEK14.59 billion.

Operations: BioArctic generates SEK299.35 million in revenue from its biotechnology segment.

Insider Ownership: 34%

Earnings Growth Forecast: 98.4% p.a.

BioArctic exemplifies a growth company with high insider ownership in Sweden. Despite recent volatility, the stock is forecasted to grow significantly, with revenue expected to increase by 42.4% per year and earnings by 98.4% annually. The company is also projected to become profitable within three years, outperforming market averages. Recent developments include promising phase-1 study results for exidavnemab and international approvals for Leqembi®, enhancing its potential in treating neurodegenerative diseases like Alzheimer's and Parkinson's.

OM:BIOA B Ownership Breakdown as at Sep 2024
OM:BIOA B Ownership Breakdown as at Sep 2024

Humble Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Humble Group AB (publ) refines, develops, and distributes fast-moving consumer products in Sweden and internationally, with a market cap of SEK 5.60 billion.

Operations: The company's revenue segments include Future Snacking (SEK 950 million), Sustainable Care (SEK 2.30 billion), Quality Nutrition (SEK 1.53 billion), and Nordic Distribution (SEK 2.67 billion).